• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡萄牙医生对前列腺癌筛查的认知、态度和实践

Prostate Cancer Screening: Knowledge, Attitudes, and Practices by Medical Doctors in Portugal.

作者信息

Braga Raquel, Morais Samantha, Pacheco-Figueiredo Luís, Araújo Natália, Lunet Nuno

机构信息

Unidade de Saúde Familiar Lagoa - ULS Matosinhos, Matosinhos, Portugal.

Institute of Public Health of the University Porto, EPIUnit ITR, University of Porto, Porto, Portugal.

出版信息

J Cancer Educ. 2025 Jun 19. doi: 10.1007/s13187-025-02665-4.

DOI:10.1007/s13187-025-02665-4
PMID:40533657
Abstract

Opportunistic prostate cancer (PCa) screening is common worldwide, with physicians playing an important role in its uptake and consequences. This study explores the knowledge, attitudes, and practices of family doctors and urologists in Portugal regarding PCa screening. A national online survey was conducted between November 2020 and February 2021. Family doctors and urologists were reached by email through their national medical associations, for a total of 596 and 63 participants from each group, respectively. Urologists considered themselves more updated with PCa screening practices than family doctors (93.0% vs. 73.1%; p < 0.001). Family doctors were more likely to consider older age (97.2% vs. 90.9%; p = 0.025) and smoking (80.6% vs. 31.7%; p < 0.001) as risk factors for PCa. Most urologists reported following the European Association of Urology Guidelines for PCa screening (90.9%), while family doctors preferred the National Guidelines (73.9%). A higher proportion of urologists believed early diagnosis is essential for improving PCa prognosis (92.9% vs. 67.9%; p < 0.001). Urologists were more likely to recommend prostate-specific antigen (PSA) testing for age group-eligible males (always or almost always: 77.2% vs. 20.4%; p < 0.001) and to perform digital rectal examination (never or rarely: 3.5% vs. 96.2%; p < 0.001). Overall, 65.1% of doctors believed that magnetic resonance imaging could improve the diagnosis of PCa in patients with high PSA levels. Family doctors and urologists differed in their knowledge, attitudes, and practices regarding PCa screening. The latter are more interventive and believe more in the benefits of PCa screening.

摘要

机会性前列腺癌(PCa)筛查在全球范围内很普遍,医生在其推广及影响方面发挥着重要作用。本研究探讨了葡萄牙家庭医生和泌尿科医生关于PCa筛查的知识、态度和实践。2020年11月至2021年2月期间进行了一项全国性在线调查。通过其国家医学协会通过电子邮件联系家庭医生和泌尿科医生,每组分别共有596名和63名参与者。泌尿科医生认为自己比家庭医生更了解PCa筛查实践(93.0%对73.1%;p<0.001)。家庭医生更倾向于将老年(97.2%对90.9%;p=0.025)和吸烟(80.6%对31.7%;p<0.001)视为PCa的危险因素。大多数泌尿科医生报告遵循欧洲泌尿外科学会PCa筛查指南(90.9%),而家庭医生更喜欢国家指南(73.9%)。更高比例的泌尿科医生认为早期诊断对于改善PCa预后至关重要(92.9%对67.9%;p<0.001)。泌尿科医生更有可能为符合年龄组的男性推荐前列腺特异性抗原(PSA)检测(总是或几乎总是:77.2%对20.4%;p<0.001),并且进行直肠指检的比例更高(从不或很少:3.5%对96.2%;p<0.001)。总体而言,65.1%的医生认为磁共振成像可以改善高PSA水平患者的PCa诊断。家庭医生和泌尿科医生在PCa筛查的知识、态度和实践方面存在差异。后者更具干预性,并且更相信PCa筛查的益处。

相似文献

1
Prostate Cancer Screening: Knowledge, Attitudes, and Practices by Medical Doctors in Portugal.葡萄牙医生对前列腺癌筛查的认知、态度和实践
J Cancer Educ. 2025 Jun 19. doi: 10.1007/s13187-025-02665-4.
2
Perspectives of clinicians and screening candidates on shared decision-making in prostate cancer screening with the prostate-specific antigen (PSA) test: a qualitative study (PROSHADE study).临床医生和筛查参与者对前列腺特异性抗原(PSA)检测用于前列腺癌筛查的共同决策的看法:一项定性研究(PROSHADE研究)
BMJ Evid Based Med. 2025 May 20;30(3):163-172. doi: 10.1136/bmjebm-2024-113113.
3
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
4
Global Delphi consensus on treatment goals for generalized pustular psoriasis.关于泛发性脓疱型银屑病治疗目标的全球德尔菲共识。
Br J Dermatol. 2025 Mar 18;192(4):706-716. doi: 10.1093/bjd/ljae491.
5
Use of β-adrenoreceptor drugs and Parkinson's disease incidence in women from the French E3N cohort study.来自法国E3N队列研究的女性中β-肾上腺素能受体药物的使用与帕金森病发病率
J Parkinsons Dis. 2025 Apr 29:1877718X251330993. doi: 10.1177/1877718X251330993.
6
Pelvic floor muscle training with feedback or biofeedback for urinary incontinence in women.针对女性尿失禁的盆底肌训练及反馈或生物反馈训练
Cochrane Database Syst Rev. 2025 Mar 11;3(3):CD009252. doi: 10.1002/14651858.CD009252.pub2.
7
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
8
Pharmacological treatment for psychotic depression.精神病性抑郁症的药物治疗。
Cochrane Database Syst Rev. 2021 Dec 7;12(12):CD004044. doi: 10.1002/14651858.CD004044.pub5.
9
Masculinity and colorectal cancer screening: a cross-sectional study of men attending state fairs in Minnesota and Wisconsin.男性气质与结直肠癌筛查:一项对参加明尼苏达州和威斯康星州州际集市的男性的横断面研究。
Ann Behav Med. 2025 Jan 4;59(1). doi: 10.1093/abm/kaaf040.
10
Molecular feature-based classification of retroperitoneal liposarcoma: a prospective cohort study.基于分子特征的腹膜后脂肪肉瘤分类:一项前瞻性队列研究。
Elife. 2025 May 23;14:RP100887. doi: 10.7554/eLife.100887.

本文引用的文献

1
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-ISUP-SIOG 前列腺癌指南-2024 更新。第一部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2024 Aug;86(2):148-163. doi: 10.1016/j.eururo.2024.03.027. Epub 2024 Apr 13.
2
Magnetic Resonance Imaging in Prostate Cancer Screening: A Systematic Review and Meta-Analysis.磁共振成像在前列腺癌筛查中的应用:系统评价和荟萃分析。
JAMA Oncol. 2024 Jun 1;10(6):745-754. doi: 10.1001/jamaoncol.2024.0734.
3
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
4
2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review.2022 年前列腺癌流行病学和风险因素的更新:系统评价。
Eur Urol. 2023 Aug;84(2):191-206. doi: 10.1016/j.eururo.2023.04.021. Epub 2023 May 16.
5
CURRENT ROLE OF MAGNETIC RESONANCE IMAGING IN THE SCREENING, DIAGNOSIS, AND TREATMENT OF PROSTATE CANCER.磁共振成像在前列腺癌筛查、诊断和治疗中的作用。
Acta Clin Croat. 2022 Oct;61(Suppl 3):92-94. doi: 10.20471/acc.2022.61.s3.14.
6
Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients.系统评价和荟萃分析前列腺特异性抗原(PSA)在有症状患者中诊断前列腺癌的准确性。
BMC Med. 2022 Feb 7;20(1):54. doi: 10.1186/s12916-021-02230-y.
7
Attitudes Toward and Use of Prostate-Specific Antigen Testing Among Urologists and General Practitioners in Germany: A Survey.德国泌尿科医生和全科医生对前列腺特异性抗原检测的态度及使用情况:一项调查
Front Oncol. 2021 Jun 4;11:691197. doi: 10.3389/fonc.2021.691197. eCollection 2021.
8
General practitioners' approaches to prostate-specific antigen testing in the north-east of the Netherlands.荷兰东北部全科医生对前列腺特异性抗原检测的方法。
BMC Fam Pract. 2020 Dec 17;21(1):270. doi: 10.1186/s12875-020-01350-3.
9
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.
10
Early detection of prostate cancer using prostate-specific antigen testing: an empirical evaluation among general practitioners and urologists.使用前列腺特异性抗原检测早期发现前列腺癌:全科医生和泌尿科医生的实证评估。
Cancer Manag Res. 2019 Apr 16;11:3079-3097. doi: 10.2147/CMAR.S193325. eCollection 2019.